Paris, France

Antonio Nobrega

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Nobrega: Innovator in Pharmaceutical Processes

Introduction

Antonio Nobrega is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of specific crystalline forms of compounds. His work is characterized by innovative processes that enhance the efficiency and effectiveness of drug development.

Latest Patents

Antonio Nobrega holds a patent for a continuous process for preparing the crystalline form II of sotagliflozin. This patent outlines a method that involves several key steps, including the reaction of a specific compound in a solution, followed by crystallization in a non-aqueous solvent medium. The process is designed to isolate the crystalline form II of sotagliflozin, which is crucial for its pharmaceutical applications. He has 1 patent to his name.

Career Highlights

Antonio is currently employed at Lexicon Pharmaceuticals, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in chemical processes has positioned him as a valuable asset to his team and the company.

Collaborations

Throughout his career, Antonio has collaborated with several professionals, including Bruno Burel and Jérome Cezerac. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Antonio Nobrega's contributions to the field of pharmaceuticals through his innovative processes exemplify the importance of continuous improvement in drug development. His work not only enhances the efficiency of pharmaceutical manufacturing but also paves the way for future advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…